In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Onyx Pharmaceuticals, which may or may not be acquired in the coming weeks, and Eli Lilly, which recently announced positive clinical trial results for an experimental cancer drug.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.